JP2013537426A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013537426A5 JP2013537426A5 JP2013524945A JP2013524945A JP2013537426A5 JP 2013537426 A5 JP2013537426 A5 JP 2013537426A5 JP 2013524945 A JP2013524945 A JP 2013524945A JP 2013524945 A JP2013524945 A JP 2013524945A JP 2013537426 A5 JP2013537426 A5 JP 2013537426A5
- Authority
- JP
- Japan
- Prior art keywords
- adenovirus
- cancer
- item
- orf3
- impaired
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37421510P | 2010-08-16 | 2010-08-16 | |
| US61/374,215 | 2010-08-16 | ||
| PCT/US2011/048005 WO2012024350A2 (en) | 2010-08-16 | 2011-08-16 | Anti-cancer adenoviruses |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013537426A JP2013537426A (ja) | 2013-10-03 |
| JP2013537426A5 true JP2013537426A5 (https=) | 2014-09-18 |
| JP5905460B2 JP5905460B2 (ja) | 2016-04-20 |
Family
ID=45605646
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013524945A Active JP5905460B2 (ja) | 2010-08-16 | 2011-08-16 | 抗がんアデノウイルス |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9187733B2 (https=) |
| EP (1) | EP2606137B1 (https=) |
| JP (1) | JP5905460B2 (https=) |
| KR (1) | KR101667094B1 (https=) |
| CN (1) | CN103180448B (https=) |
| AU (1) | AU2011292119B2 (https=) |
| BR (1) | BR112013003579A2 (https=) |
| CA (1) | CA2807778C (https=) |
| SG (1) | SG187785A1 (https=) |
| WO (1) | WO2012024350A2 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG187785A1 (en) * | 2010-08-16 | 2013-03-28 | Salk Inst For Biological Studi | Anti-cancer adenoviruses |
| CA3215250A1 (en) * | 2012-03-13 | 2013-09-19 | Salk Institute For Biological Studies | Selective cell targeting using adenovirus and chemical dimers |
| AU2014236207B2 (en) | 2013-03-14 | 2019-05-23 | Salk Institute For Biological Studies | Oncolytic adenovirus compositions |
| KR20250081944A (ko) | 2014-09-24 | 2025-06-05 | 솔크 인스티튜트 포 바이올로지칼 스터디즈 | 종양 살상 바이러스 및 이의 사용방법 |
| EP3359175B1 (en) | 2015-10-05 | 2020-09-16 | Salk Institute for Biological Studies | Synthetic adenoviruses with tropism to damaged tissue for use in promoting wound repair and tissue regeneration |
| WO2017147265A1 (en) | 2016-02-23 | 2017-08-31 | Salk Institute For Biological Studies | High throughput assay for measuring adenovirus replication kinetics |
| EP4155411A1 (en) | 2016-02-23 | 2023-03-29 | Salk Institute for Biological Studies | Exogenous gene expression in therapeutic adenovirus for minimal impact on viral kinetics |
| EP3532082A4 (en) | 2016-12-12 | 2020-08-26 | Salk Institute for Biological Studies | SYNTHETIC ADENOVIRUS TUMOR TARGETING AND THEIR USES |
| MX2019013259A (es) | 2017-05-08 | 2020-01-13 | Gritstone Oncology Inc | Vectores de neoantigeno de alfavirus. |
| MX2020010499A (es) | 2018-04-09 | 2020-10-28 | Salk Inst For Biological Studi | Composiciones de adenovirus oncoliticas con propiedades aumentadas de replicacion. |
| MX2021014525A (es) * | 2019-05-30 | 2022-03-17 | Gritstone Bio Inc | Adenovirus modificados. |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA137094A (en) | 1911-08-31 | 1911-11-28 | Sheppe, Alice L. | Cloth measuring and price calculating machine |
| FR2726285B1 (fr) * | 1994-10-28 | 1996-11-29 | Centre Nat Rech Scient | Adenovirus depourvus de particules contaminantes viables, preparation et utilisation |
| ES2210081T3 (es) * | 1998-07-07 | 2004-07-01 | Transgene S.A. | Utilizacion de los marcos de lectura de la region e4 para la mejora de la expresion de genes. |
| EP1083229A1 (en) * | 1999-09-10 | 2001-03-14 | Introgene B.V. | Modified adenoviral vectors for use in gene therapy |
| WO2001090392A1 (en) * | 2000-05-26 | 2001-11-29 | Sumitomo Pharmaceuticals Company, Limited | Novel recombinant adenovirus vector with relieved side effects |
| US20020106382A1 (en) * | 2000-07-14 | 2002-08-08 | Young Charles S.H. | Modified adenovirus and uses thereof |
| US20030220284A1 (en) | 2002-02-22 | 2003-11-27 | Patricia Yotnda | Delivery of adenoviral DNA in a liposomal formulation for treatment of disease |
| EP1499332A4 (en) | 2002-04-29 | 2006-12-06 | Hadasit Med Res Service | COMPOSITIONS AND METHODS FOR TREATING CANCER WITH A VIRAL ONCOLYTIC AGENT |
| EP1545627A4 (en) | 2002-10-01 | 2006-12-27 | Univ Duke | TARGETED TUMOR THERAPY THROUGH THE USE OF RECOMBINANT ADENOVIRUS VECTORS FOR SELECTIVE REPLICATION IN HYPOXIC TUMOR REGIONS |
| US20050201978A1 (en) | 2003-11-17 | 2005-09-15 | Lipton James S. | Tumor and infectious disease therapeutic compositions |
| JP2012504140A (ja) * | 2008-09-26 | 2012-02-16 | オーバーン・ユニバーシティ | 非複製性ベクターワクチンの粘膜投与による鳥類の免疫処置 |
| SG187785A1 (en) * | 2010-08-16 | 2013-03-28 | Salk Inst For Biological Studi | Anti-cancer adenoviruses |
-
2011
- 2011-08-16 SG SG2013009790A patent/SG187785A1/en unknown
- 2011-08-16 AU AU2011292119A patent/AU2011292119B2/en active Active
- 2011-08-16 JP JP2013524945A patent/JP5905460B2/ja active Active
- 2011-08-16 BR BR112013003579A patent/BR112013003579A2/pt not_active Application Discontinuation
- 2011-08-16 CA CA2807778A patent/CA2807778C/en active Active
- 2011-08-16 EP EP11818698.0A patent/EP2606137B1/en active Active
- 2011-08-16 KR KR1020137006526A patent/KR101667094B1/ko active Active
- 2011-08-16 CN CN201180050032.7A patent/CN103180448B/zh active Active
- 2011-08-16 WO PCT/US2011/048005 patent/WO2012024350A2/en not_active Ceased
-
2013
- 2013-02-15 US US13/768,933 patent/US9187733B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013537426A5 (https=) | ||
| Barkauskas et al. | Cellular mechanisms of tissue fibrosis. 7. New insights into the cellular mechanisms of pulmonary fibrosis | |
| AR090470A1 (es) | Vacuna contra el virus sincicial respiratorio (rsv) | |
| MX2024005757A (es) | Virus pichinde de tres segmentos como vectores de vacunas. | |
| RU2016123086A (ru) | Способы и композиции для лечения болезни хантингтона | |
| BR112016020688A2 (pt) | Composições úteis no tratamento da deficiência da ornitina transcarbamilase (otc) | |
| EA201490004A1 (ru) | Применение bifidobacterium lactis bl-04 для лечения заболеваний дыхательных путей | |
| JP2013530155A5 (https=) | ||
| EA201301173A1 (ru) | Клональные штаммы аттенуированных вакцинирующих вирусов и способы их использования | |
| SG10201901482XA (en) | Oncolytic adenovirus encoding a b7 protein | |
| FR2981643B1 (fr) | Procede de preparation d'un materiau composite silicium/carbone, materiau ainsi prepare, et electrode notamment electrode negative, comprenant ce materiau. | |
| JP2013509429A5 (https=) | ||
| WO2015061294A3 (en) | Use of sting agonists to treat chronic hepatitis b virus infection | |
| BR112014015016A8 (pt) | Proteína homodimérica de duas cadeias de aminoácidos idênticas, cadeia de aminoácido, molécula de ácido nucléico, composição farmacêutica, célula hospedeira, método de preparação de uma proteína homodimérica, método para preparação de uma vacina, vacina e método de tratamento ou prevenção | |
| BR112015025464A2 (pt) | coagonistas do receptor de glp-1/glucagon estáveis, prolongados para uso médico | |
| MX2015001122A (es) | Combinaciones farmaceuticas de un inhibidor de cdk4/6 y un inhibidor de b-raf. | |
| FI3581650T3 (fi) | IX-tekijän polypeptidimutantti, sen käyttöjä ja menetelmä sen valmistamiseksi | |
| JP2011157399A5 (https=) | ||
| NZ628385A (en) | Batches of recombinant adenovirus with altered terminal ends | |
| BR112014028315A2 (pt) | mposto, métodos para introdução de uma molécula dentro do citosol de uma célula, para obter a morte de uma célula, para expressar uma molécula antigênica ou uma parte da mesma na superfície de uma célula, e para tratamento ou prevenção de uma doença, distúrbio ou infecção em um paciente, composição farmacêutica, célula ou uma população de células, e, kit | |
| JP2017532343A5 (https=) | ||
| MA39096B1 (fr) | Anticorps spécifiques à fcrn | |
| MD4481B1 (ro) | Herpesvirus recombinant Koi (KHV) şi vaccin pentru profilaxia bolii cauzate de KHV | |
| EA201401353A1 (ru) | Биомаркеры для определения эффективной ответной реакции на лечение пациентов с гепатоцеллюлярной карциномой (гцк) | |
| JP2018512597A5 (https=) |